Korea FilingsFull brief — $39

SAM CHUN DANG PHARM CO. LTD

삼천당제약(주) · KOSDAQ: 000250 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
삼천당제약(주)
Market / ticker
KOSDAQ · 000250
Industry
Pharmaceuticals and medicinal chemicals
Established
1943-12-29
Fiscal year ends
December
Website
www.scd.co.kr
DART corp code
00128546
Latest revenue
₩231.8B (FY2025)

Items worth checking

high
Unfaithful disclosure designation — filed on 2 separate dates in the last 12 months, latest 2026-04-20.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩192.7B₩210.9B₩231.8B
Operating income₩9.6B₩2.6B₩8.5B
Net income−₩4.2B−₩5.1B₩12.0B
Total assets₩408.0B₩519.8B₩561.2B
Total liabilities₩109.6B₩170.4B₩197.6B
Total equity₩298.5B₩349.4B₩363.6B
Share capital₩11.7B₩11.7B₩11.7B

Consolidated statements · FY2025 operating margin 3.7% · liabilities to equity 54% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 82 (current)선진회계법인Unqualified
Term 81 (prior)선진회계법인Unqualified
Term 80 (two years prior)진일회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-08-14Large shareholding (5%+) reportDART
2026-08-14Half-year report (2026.06)DART
2026-08-05Amended: Material management matterDART
2026-08-05Amended: Material management matterDART
2026-07-23Large shareholding (5%+) reportDART
2026-06-30Independent director appointment / dismissal / resignationDART
2026-06-30Extraordinary shareholders meeting resultsDART
2026-06-12Notice of shareholders meetingDART
2026-06-10Investor relations eventDART
2026-06-04Amended: Annual report (2025.12)DART
2026-05-29Material management matterDART
2026-05-15Quarterly report (2026.03)DART
2026-04-27Record date / shareholder register closure setDART
2026-04-27Independent director appointment / dismissal / resignationDART
2026-04-27Resolution to convene shareholders meetingDART
2026-04-20Designated for unfaithful disclosureDART
2026-04-16Amended: Investor relations eventDART
2026-04-06Officer / major shareholder trading plan withdrawnDART
2026-03-31Designated for unfaithful disclosureDART
2026-03-30Independent director appointment / dismissal / resignationDART

Showing the 20 most recent of 51 filings. The full brief lists all of them.

Full brief on SAM CHUN DANG PHARM CO. LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.